Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Premature Birth 1Patient Compliance 1Neoplasms 1Hirschsprung Disease 1Heart Defects, Congenital 1Congenital Abnormalities 1Child Nutrition Disorders 1Acquired Immunodeficiency Syndrome 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Self Care × 90 days × Clear all
NCT04150120 2026-04-06

eChildHealth

Lund University

Phase NA Completed
720 enrolled

Congenital Abnormalities, Acquired Immunodeficiency Syndrome, Heart Defects, Congenital, Hirschsprung Disease, Neoplasms, Patient Compliance, Child Nutrition Disorders, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡